Disease & Conditions Key Differences Between Mpox and COVID-19

------------
This article outlines the key differences between Mpox and COVID-19, focusing on transmission, symptoms, and severity. The WHO reassures the public that Mpox is not as contagious or severe as COVID-19, with distinct differences in its spread and impact.
------------

As the World Health Organisation (WHO) works to reassure the global community, it's crucial to understand that Mpox (formerly known as monkeypox) is not the new COVID-19. Here are the key differences:

1. Transmission:
   • Mpox: Spread primarily through close physical contact, particularly skin-to-skin, and contact with contaminated objects.
   • COVID-19: Primarily airborne, spreading through respiratory droplets.
2. Symptoms:
   • Mpox: Characterised by fever, rash, and swollen lymph nodes, often leading to visible skin lesions.
   • COVID-19: Symptoms range from fever, cough, and shortness of breath to loss of taste or smell, and severe cases can lead to respiratory issues.
3. Infectivity:
   • Mpox: Less contagious, requires prolonged contact, and has limited human-to-human transmission.
   • COVID-19: Highly contagious and can spread rapidly in crowded or enclosed spaces.
4. Mortality Rate:
   • Mpox: Generally low mortality, with most cases being mild.
   • COVID-19: Variable, but can be high, especially in older adults or those with underlying health conditions.
5. Vaccine Availability:
   • Mpox: Vaccines exist, especially for those at higher risk, similar to smallpox vaccines.
   • COVID-19: Multiple vaccines are widely available and administered globally.

While both are serious diseases, Mpox and COVID-19 differ significantly in their spread, symptoms, and impact. The WHO urges caution but reassures that Mpox is less easily transmissible or severe than COVID-19.